HWM
AMPH icon

Hohimer Wealth Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Hohimer Wealth Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$265K Buy
13,128
+62
+0.5% +$1.25K 0.03% 291
2026
Q1 		$256K Buy
+13,066
New +$320K 0.03% 258
2025
Q4 		– Sell
-11,972
Closed -$319K – 321
2025
Q3 		$319K Buy
11,972
+127
+1% +$3.28K 0.04% 222
2025
Q2 		$272K Buy
11,845
+3,840
+48% +$95.3K 0.05% 189
2025
Q1 		$232K Buy
8,005
+520
+7% +$16.6K 0.05% 223
2024
Q4 		$278K Buy
7,485
+491
+7% +$22.5K 0.05% 187
2024
Q3 		$339K Buy
+6,994
New +$307K 0.07% 159

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Hohimer Wealth Management's AMPH Position: Q2 2026 in Review

Hohimer Wealth Management increased its Amphastar Pharmaceuticals (AMPH) stake by 0.47% in Q2 2026, buying an estimated $1.25K and bringing the position to 13,128 shares worth $265K. The position accounts for 0.03% of the portfolio, ranked #291.

Hohimer Wealth Management first reported a position in AMPH in Q3 2024 and has held it in 7 quarters since. The position peaked at $339K in Q3 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Hohimer Wealth Management held 13,128 shares of Amphastar Pharmaceuticals worth $265K as of Q2 2026.
  • Hohimer Wealth Management bought 62 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.25K.
  • Amphastar Pharmaceuticals made up 0.03% of Hohimer Wealth Management's portfolio in Q2 2026, its #291 holding.
  • Hohimer Wealth Management first reported a position in Amphastar Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Hohimer Wealth Management's Amphastar Pharmaceuticals position peaked at $339K in Q3 2024.
  • 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Hohimer Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.